CRL Q2 2020 Earnings Report — Charles River Laboratories International, Inc. Revenue & Financial Results | Market Cap Arena

Charles River Laboratories International, Inc.CRL

Q2 2020 Earnings

Reported August 5, 2020

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q2 2020	Q1 2020	Q2 2019	QoQ Change	YoY Change
Revenue	$683M	$707M	—	-3.5%	—
Op. Income	$77M	$94M	—	-18.6%	—
Gross Margin	34.0%	35.6%	—	-1.6pp	—
Net Margin	9.9%	7.2%	—	2.7pp	—
EPS (Diluted)	$1.34	$1.02	—	31.4%	—
Free Cash Flow	$136M	$43M	—	216.1%	—

Revenue Flow

Item	Amount
REVENUE	$683M
Cost of Revenue	$450M
GROSS PROFIT	$232M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$128M
Other Expenses	$28M
Operating Expenses	$155M
Cost & Expenses	$606M
OPERATING INCOME	$77M
Interest Income	$276.0K
Interest Expense	$19M
Other Income/Expenses	$7M
INCOME BEFORE TAX	$84M
Income Tax Expense	$16M
Net Income from Continuing Ops	$68M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$67M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$67M
D&A	$57M
EBIT	$103M
EBITDA	$161M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$683M
Cost of Revenue	$450M
GROSS PROFIT	$232M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$128M
Other Expenses	$28M
Operating Expenses	$155M
Cost & Expenses	$606M
OPERATING INCOME	$77M
Interest Income	$276.0K
Interest Expense	$19M
Other Income/Expenses	$7M
INCOME BEFORE TAX	$84M
Income Tax Expense	$16M
Net Income from Continuing Ops	$68M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$67M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$67M
D&A	$57M
EBIT	$103M
EBITDA	$161M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$68M
Depreciation & Amortization	$57M
Stock-Based Compensation	$13M
Deferred Income Tax	$3M
Other Non-Cash Items	-$24M
Change in Working Capital	$45M
OPERATING CASH FLOW	$162M
Capital Expenditure	-$27M
Acquisitions (Net)	$0
Purchases of Investments	-$5M
Sales/Maturities of Investments	$3M
Other Investing Activities	-$60.0K
NET CASH FROM INVESTING	-$29M
Net Debt Issuance	-$118M
Common Stock Repurchased	-$118.0K
Common Dividends Paid	$0
Other Financing Activities	$14M
NET CASH FROM FINANCING	-$104M
FREE CASH FLOW	$136M
Net Change in Cash	$30M

Balance Sheet

Item	Amount
Cash & Equivalents	$402M
Short-Term Investments	$929.0K
Net Receivables	$533M
Inventory	$168M
Other Current Assets	$772.0K
TOTAL CURRENT ASSETS	$1.2B
PP&E (Net)	$1.2B
Goodwill	$1.7B
Intangible Assets	$806M
Long-Term Investments	$142M
Tax Assets	$43M
Other Non-Current Assets	$83M
TOTAL NON-CURRENT ASSETS	$4.0B
TOTAL ASSETS	$5.2B
Account Payables	$83M
Short-Term Debt	$51M
Deferred Revenue	$212M
Other Current Liabilities	$179M
TOTAL CURRENT LIABILITIES	$728M
Long-Term Debt	$2.2B
Deferred Revenue NC	$16M
Deferred Tax Liabilities	$202M
Other Non-Current Liabilities	$160M
TOTAL NON-CURRENT LIABILITIES	$2.7B
TOTAL LIABILITIES	$3.5B
Common Stock	$498.0K
Additional Paid-In Capital	$1.6B
Retained Earnings	$399M
Treasury Stock	-$24M
Accum. Other Comp. Income	-$213M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$1.8B
Minority Interest	$28M
TOTAL EQUITY	$1.8B
TOTAL LIABILITIES & EQUITY	$5.2B
Total Debt	$2.4B
Net Debt	$2.0B